1. bookVolumen 58 (2020): Heft 2 (June 2020)
Zeitschriftendaten
License
Format
Zeitschrift
eISSN
2501-062X
Erstveröffentlichung
30 Mar 2015
Erscheinungsweise
4 Hefte pro Jahr
Sprachen
Englisch
Uneingeschränkter Zugang

Efficacy of 4-hour rescue therapeutic plasma exchange in severe septic shock patients

Online veröffentlicht: 02 Jun 2020
Volumen & Heft: Volumen 58 (2020) - Heft 2 (June 2020)
Seitenbereich: 75 - 80
Eingereicht: 28 Sep 2019
Zeitschriftendaten
License
Format
Zeitschrift
eISSN
2501-062X
Erstveröffentlichung
30 Mar 2015
Erscheinungsweise
4 Hefte pro Jahr
Sprachen
Englisch

1. CARCILLO J.A., KELLUM J.A., Is there a role for plasmapheresis/plasma exchange therapy in septic shock, MODS, and thrombocytopenia-associated multiple organ failure? We still do not know – but perhaps we are closer, Intensive Care. Med., 2002, Oct., 28: 1373–5.10.1007/s00134-002-1428-x12373459Search in Google Scholar

2. RHODES A., EVANS L.E., ALHAZZANI W., LEVY M.M., ANTONELLI M., FERRER R. et al., Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016, Intensive Care. Med., 2017, Mar., 43(3): 304–377.Search in Google Scholar

3. HJORTH V., STENLUND G., Plasmapheresis as part of the treatment for septic shock, Scand. J. Infect. Dis., 2000, 32: 511–4.10.1080/00365540045879411055656Search in Google Scholar

4. SCHMIDT J., MANN S., MOHR V.D., LAMPERT R., FIRLA U., ZIRNGIBL H., Plasmapheresis combined with continuous venovenous hemofiltration in surgical patients with sepsis, Intensive Care. Med., 2000, 26: 532–7.10.1007/s00134005120010923726Search in Google Scholar

5. RONCO C., BRENDOLAN A., LONNEMANN G., BELLOMO R., PICCINNI P., DIGITO A., A pilot study of coupled plasma filtration with adsorption in septic shock, Crit. Care. Med., 2002, 30: 1250–1255.10.1097/00003246-200206000-0001512072677Search in Google Scholar

6. BUSUND R., KOUKLINE V., UTROBIN U., NEDASHKOVSKY E., Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial, Intensive Care. Med., 2002, Oct., 28: 1434–9.10.1007/s00134-002-1410-712373468Search in Google Scholar

7. ATAMAN K., JEHMLICH M., KOCK S., NEUMANN S., LEISCHIK M., FILIPOVIC Z., HOPF H.B., Short-term cardiovascular effects of plasmapheresis in norepinephrine-refractory septic shock, Intensive Care. Med., 2002, 28: 1164–1167.10.1007/s00134-002-1375-612185443Search in Google Scholar

8. STEGMAYR B.G., BANGA R., BERGGREN L., NORDA R., RYDVALL A., VIKERFORS T., Plasma exchange as rescue therapy in multiple organ failure including acute renal failure, Crit. Care. Med., 2003, Jun., 31: 1730–6.10.1097/01.CCM.0000064742.00981.1412794412Search in Google Scholar

9. JOHANNES HADEM, CARSTEN HAFER, ANDREA S. SCHNEIDER, OLAF WIESNER, GERNOT BEUTEL, THOMAS FUEHNER, TOBIAS WELTE, MARIUS M. HOEPER et al., Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective observational single-centre study of 23 patients, BMC Anesthesiol., 2014, 14: 24.10.1186/1471-2253-14-24398646724708653Search in Google Scholar

10. SCHOENBERG M.H., WEISS M., RADERMACHER P., Outcome of patients with sepsis and septic shock after ICU treatment, Langenbecks Arch. Surg., 1998, Mar., 383: 44–8.10.1007/s0042300500909627170Search in Google Scholar

11. LEVY M.M., DELLINGER R.P., TOWNSEND S.R. et al., Surviving Sepsis Campaign. The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis, Crit. Care. Med., 2010, 38: 367–374.10.1097/CCM.0b013e3181cb0cdc20035219Search in Google Scholar

12. LEVY M.M., RHODES A., PHILLIPS G.S. et al., Surviving Sepsis Campaign: Association between performance metrics and outcomes in a 7.5-year study, Crit. Care. Med., 2015, 43: 3–12.10.1097/CCM.000000000000072325275252Search in Google Scholar

13. LEVY M.M., PRONOVOST P.J., DELLINGER R.P. et al., Sepsis change bundles: Converting guidelines into meaningful change in behavior and clinical outcome, Crit. Care. Med., 2004, 32: S595–S597.10.1097/01.CCM.0000147016.53607.C415542969Search in Google Scholar

14. DAMIANI E., DONATI A., SERAFINI G. et al., Effect of performance improvement programs on compliance with sepsis bundles and mortality: A systematic review and meta-analysis of observational studies, PLoS One, 2015, 10: e0125827.10.1371/journal.pone.0125827442271725946168Search in Google Scholar

15. RHODES A., PHILLIPS G., BEALE R. et al., The Surviving Sepsis Campaign bundles and outcome: Results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study), Intensive Care. Med., 2015, 41: 1620–1628.10.1007/s00134-015-3906-y26109396Search in Google Scholar

16. DWYER J., One Boy’s Death Moves State to Action to Prevent Others, 2012, Available at: http://www.nytimes.com/2012/12/21/nyregion/one-boys-death-moves-state-to-action-to-prevent-others.html, Accessed December 27, 2017.Search in Google Scholar

17. SEYMOUR C.W., GESTEN F., PRESCOTT H. et al., Time to treatment and mortality during mandated emergency care for sepsis, N. Engl. J. Med., 2017, 376: 2235–2244.10.1056/NEJMoa1703058553825828528569Search in Google Scholar

18. LIU V.X., MOREHOUSE J.W., MARELICH G.P. et al., Multicenter implementation of a treatment bundle for patients with sepsis and intermediate lactate values, Am. J. Respir. Crit. Care. Med., 2016, 193: 1264–1270.10.1164/rccm.201507-1489OC491089826695114Search in Google Scholar

19. LEISMAN D.E., DOERFLER M.E., WARD M.F. et al., Survival benefit and cost savings from compliance with a simplified 3-hour sepsis bundle in a series of prospective, multisite, observational cohorts, Crit. Care. Med., 2017, 45: 395–406.10.1097/CCM.000000000000218427941371Search in Google Scholar

20. FERRER R., MARTIN-LOECHES I., PHILLIPS G. et al., Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: Results from a guideline-based performance improvement program, Crit. Care. Med., 2014, 42: 1749–1755.10.1097/CCM.000000000000033024717459Search in Google Scholar

21. KUMAR A., ROBERTS D., WOOD K.E. et al., Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock, Crit. Care. Med., 2006, 34: 1589–1596.10.1097/01.CCM.0000217961.75225.E916625125Search in Google Scholar

22. KUMAR A., Systematic bias in meta-analyses of time to antimicrobial in sepsis studies, Crit. Care. Med., 2016, 44: e234–e235.10.1097/CCM.000000000000151226974458Search in Google Scholar

23. SEYMOUR C.W., LIU V.X., IWASHYNA T.J. et al., Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), JAMA, 2016, 315: 762–774.10.1001/jama.2016.0288543343526903335Search in Google Scholar

24. HOEPER M.M., ABOU-REBYEH F., ATHMAN C., SCHWARZ A., Plasmapheresis in streptococcal toxic shock syndrome, Crit. Care. Med., 2001, 29: 2399.10.1097/00003246-200112000-0003311801855Search in Google Scholar

Empfohlene Artikel von Trend MD

Planen Sie Ihre Fernkonferenz mit Scienceendo